GENinCode (GENI) Competitors

GENinCode (LON:GENI) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

Does the MarketBeat Community favor GENI or ABDX?

GENinCode and Abingdon Health both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
GENinCode	N/A	N/A
Abingdon Health	N/A	N/A

Which has higher valuation and earnings, GENI or ABDX?

Abingdon Health has higher revenue and earnings than GENinCode. Abingdon Health is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£1.72M	8.59	-£6.73M	-£0.06	-139.17
Abingdon Health	£5.34M	2.59	-£2.23M	-£0.01	-1,089.90

Do institutionals & insiders believe in GENI or ABDX?

41.6% of GENinCode shares are owned by institutional investors. Comparatively, 10.6% of Abingdon Health shares are owned by institutional investors. 29.5% of GENinCode shares are owned by insiders. Comparatively, 56.1% of Abingdon Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is GENI or ABDX more profitable?

GENinCode has a net margin of 0.00% compared to Abingdon Health's net margin of -41.82%. Abingdon Health's return on equity of -76.65% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	N/A	-84.23%	-43.64%
Abingdon Health	-41.82%	-76.65%	-26.52%

Do analysts prefer GENI or ABDX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GENinCode	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Abingdon Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has more volatility & risk, GENI or ABDX?

GENinCode has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500.

Does the media prefer GENI or ABDX?

In the previous week, Abingdon Health had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for GENinCode. Abingdon Health's average media sentiment score of 0.76 beat GENinCode's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
GENinCode	Neutral
Abingdon Health	Positive

Summary

Abingdon Health beats GENinCode on 8 of the 13 factors compared between the two stocks.